We don’t have a summary available yet.
The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress, and was published on Nov 17, 2020.
Block, Report, And Suspend Suspicious Shipments Act of 2020
This bill creates additional requirements for drug manufacturers and distributors who discover a suspicious order for controlled substances.
In addition to reporting the suspicious order to the Drug Enforcement Administration (DEA), a manufacturer or distributor must also exercise due diligence and decline to fill the order.
The DEA must issue regulations specifying the indicators that give rise to a suspicious order.